Court Grants Teva-Ivax Bid For Zocor Exclusivity
Teva confirmed on Monday that it had been granted summary judgment by the U.S. District Court for the District of Columbia, triggering hopes that Ivax will finally win exclusivity following a six-year crusade to sell generic Zocor.
The development serves as welcome news for Teva,...
Already a subscriber? Click here to login